Sale

Oxygen Therapy Market

Global Oxygen Therapy Market Size, Price, Trends: By Product Type: Oxygen Source Equipment, Oxygen Delivery Devices; By Applications: Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Oxygen Therapy Market Outlook

The global oxygen therapy market size attained a value of USD 38.45 billion in 2023. The market is anticipated to grow at a CAGR of 7.7% during the forecast period of 2024-2032 to attain a value of USD 74.96 billion by 2032.

 

Oxygen Therapy Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rise of Chronic Respiratory Diseases Owing to Surging Pollution and Tobacco Smoking Aiding the Market Growth

According to the World Health Organisation (WHO), more than 1 billion people in the world suffer from chronic respiratory issues. The rising cases of chronic obstructive pulmonary disease (COPD) caused by rising pollution levels and tobacco smoking are increasing the demand for supplement oxygen to improve survival chances and improve the quality of life of the patients. This is augmenting the growth of the oxygen therapy industry. Moreover, the rising awareness regarding hypoxaemia, which is one of the leading causes of child deaths worldwide, requires the use of supplement oxygen and is further boosting the market growth. The increasing efforts by UNICEF to provide oxygen concentrators in various countries are also aiding the market growth.

The growing geriatric population in Europe who are more prone to respiratory problems is providing further impetus to the market growth. Moreover, the introduction of favourable government incentives to aid the treatment of chronic illness and provide required supplement oxygen are further invigorating the market growth. Furthermore, increasing innovations to provide personalised and efficient oxygen therapy at home is also fuelling the industry growth. The market in North America is rapidly growing owing to escalating research and development (R&D) and the adoption of the latest technological advancements by the leading companies. Moreover, they are investing in digital marketing and expanding their online presence, which is also accelerating the industry growth, further contributing to the overall market growth.

 

Oxygen Therapy: Market Segmentation

Oxygen therapy, variously known as supplement oxygen, is a treatment that provides oxygen to patients with breathing disorders. It aids in improving the energy level, sleep, and quality of life of patients. Oxygen can be supplied through various ways, including face masks, nasal cannula, and bag valve masks, among others.

 

Global Oxygen Therapy Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on the products, the market is divided into:

  • Oxygen Source Equipment
  • Oxygen Cylinders
  • Oxygen Concentrators
  • Liquid Oxygen Devices
  • PAP Devices
  • Oxygen Delivery Devices
  • Oxygen Masks
  • Nasal Cannula
  • Venturi Masks
  • Non-Rebreather Masks
  • Bag Valve Masks
  • CPAP Masks
  • Others

The major applications of oxygen therapy are:

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Others

The market can be broadly categorised on the basis of its end uses into:

  • Home Healthcare
  • Hospitals

The EMR report looks into the regional markets of oxygen therapy like North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa.

 

Global Oxygen Therapy Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Cases of Pneumonia Owing to the Second Wave of the Coronavirus Pandemic to Bolster the Market Growth

The demand for oxygen therapy is increasing significantly due to the surge of the coronavirus pandemic. As COVID-19 can lead to pneumonia and make it difficult or impossible to breathe, patients require supplement oxygen, which is augmenting the market growth. The escalating demand for oxygen supplements in hospitals due to the pandemic is further aiding the market. Moreover, the development of COVID speciality hospitals in various countries to contain the virus is also increasing the demand for oxygen therapy, consequently propelling the market growth. In addition, the growing demand for portable oxygen concentrators for patients in home isolation is further driving the market growth.

The surge of the second wave of the pandemic in various countries, such as India, Laos, Nepal, Singapore, South Africa, and Cambodia, among others, is resulting in the mutations of the virus and the development of deadlier strains, which, in turn, is increasing the demand for oxygen supplements, consequently facilitating the market growth. The increasing investments by the governments and major companies to aid the demand for oxygen cylinders and concentrators are also boosting the market growth. Moreover, with the rising technological advancements and the adoption of innovative practices, major companies are developing superior oxygen therapy for home healthcare. The companies are investing in research and development (R&D) to develop cost-effective, disposable, risk-free, and advanced products for oxygen therapy. This is expected to catalyse the market growth further.

 

Key Industry Players in the Global Oxygen Therapy Market

The report presents a detailed analysis of the following key players in the global oxygen therapy market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Hersill S.L.
  • Philips Respironics, Inc.
  • DeVilbiss Healthcare LLC
  • Smiths Group plc
  • Teleflex Incorporated
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Applications
  • End User
  • Region
Breakup by Product Type
  • Oxygen Source Equipment
  • Oxygen Delivery Devices
Breakup by Applications
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Pneumonia
  • Others
Breakup by End User
  • Hospitals
  • Clinics
  • Rehab Centers
  • Home Healthcare
  • Non-home Healthcare
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • General Electric
  • Tecno-Gaz S.p.A
  • HERSILL
  • Koninklijke Philips N.V.
  • DeVilbiss Healthcare LLC
  • Smith Group plc.
  • Allied Healthcare Products, Inc.
  • Teleflex Incorporated
  • Invacare Corporation
  • Thermo Fisher Scientific Inc.
  • Essex Industries, Inc.
  • OxyBand Technologies
  • Nidek Medical Products, Inc
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope
    1.4    Research Methodology
2    Executive Summary
3    Global Oxygen Therapy Market Overview 

    3.1    Global Oxygen Therapy Market Historical Value (2017-2023) 
    3.2    Global Oxygen Therapy Market Forecast Value (2024-2032)
4    Global Oxygen Therapy Market Landscape
    4.1    Global Oxygen Therapy Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Oxygen Therapy Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Applications
        4.2.3    Analysis by End User
5    Global Oxygen Therapy Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Oxygen Therapy Market Segmentation
    6.1    Global Oxygen Therapy Market by Product Type
        6.1.1    Market Overview
        6.1.2    Oxygen Source Equipment
            6.1.2.1    Oxygen Cylinders
                6.1.2.1.1    Fixed
                6.1.2.1.2    Portable
            6.1.2.2    Oxygen Concentrators
                6.1.2.2.1    Fixed
                6.1.2.2.2    Portable
            6.1.2.3    Liquid Oxygen Devices
            6.1.2.4    PAP Devices
                6.1.2.4.1    CPAP
                6.1.2.4.2    APAP
                6.1.2.4.3    Bi-PAP
        6.1.3    Oxygen Delivery Devices
            6.1.3.1    Oxygen Masks
            6.1.3.2    Nasal Cannula
            6.1.3.3    Venturi Masks
            6.1.3.4    Non-rebreather Masks
            6.1.3.5    Bag Valve Masks
            6.1.3.6    CPAP Masks
            6.1.3.7    Others
    6.2    Global Oxygen Therapy Market by Applications
        6.2.1    Market Overview
        6.2.2    Chronic Obstructive Pulmonary Disease
        6.2.3    Asthma
        6.2.4    Obstructive Sleep Apnea
        6.2.5    Respiratory Distress Syndrome
        6.2.6    Cystic Fibrosis
        6.2.7    Pneumonia
        6.2.8    Others
    6.3    Global Oxygen Therapy Market by End User
        6.3.1    Market Overview
        6.3.2    Hospitals
        6.3.3    Clinics
        6.3.4    Rehab Centers
        6.3.5    Home Healthcare
        6.3.6    Non-home Healthcare
    6.4    Global Oxygen Therapy Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Oxygen Therapy Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Oxygen Therapy Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Oxygen Therapy Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Oxygen Therapy Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Oxygen Therapy Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    General Electric
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Tecno-Gaz S.p.A 
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    HERSILL
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Koninklijke Philips N.V.
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    DeVilbiss Healthcare LLC
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Smith Group plc. 
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Allied Healthcare Products, Inc.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Teleflex Incorporated
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Invacare Corporation
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Thermo Fisher Scientific Inc.
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Essex Industries, Inc.
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    OxyBand Technologies
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    Nidek Medical Products, Inc
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
18    Global Oxygen Therapy Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The oxygen therapy market was valued at USD 38.45 billion in 2023.

The market is expected to grow at a CAGR of 7.7% from 2024 to 2032 to reach a value of USD 74.96 billion by 2032.

The market is being aided by the rising cases of chronic respiratory diseases, which requires supplement oxygen for the wellbeing of patients.

The market is driven by increasing research and development (R&D) by the leading players, the rising prevalence of portable oxygen concentrators, and the surging cases of pneumonia during the coronavirus pandemic.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major products of oxygen therapy in the industry are oxygen source equipment and oxygen delivery devices.

The dominant applications of oxygen therapy are chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, and cystic fibrosis, among others.

The significant end uses in the market are home healthcare and hospitals.

The major players in the industry are Hersill S.L., Philips Respironics, Inc., DeVilbiss Healthcare LLC, Smiths Group plc, and Teleflex Incorporated, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER